1621 Central Avenue
Cheyenne, WY 82001
United States
206-734-4738
https://www.evbiologics.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 284
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Daniel S. McKinney | Founder, Chairman & CEO | N/D | N/D | 1962 |
Mr. Monte Fisher | Chief Financial Officer | N/D | N/D | N/D |
Mr. William Bossung | Corporate Finance Director & Corporate Secretary | N/D | N/D | N/D |
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
La calificación ISS Governance QuickScore de EV Biologics, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.